High-dose vitamin C shows promise in pancreatic cancer treatment
Cancer Center expert featured in Local 12 report
The University of Cincinnati Cancer Center's Olugbenga Olowokure was featured in a Local 12 story discussing new research from the University of Iowa published in the journal Redox Biology that suggests that high doses of vitamin C, when combined with standard chemotherapy, may significantly extend the life expectancy of patients with advanced pancreatic cancer.
Olowokure was not involved in the study, but reviewed it and explained 18 patients in the study received 75 grams of high-dose vitamin C intravenously three times a week in addition to standard of care chemotherapy.
"By getting a significant higher amount of vitamin C within your bloodstream, you are actually able to generate hydrogen peroxide," said Olowokure, MD, professor in the Department of Internal Medicine at UC's College of Medicine and director of inpatient service at UC Medical Center.
This appears to combat tumor cells, as the study found the patients receiving high-dose vitamin C had longer progression-free survival. Patients in the high-dose group had a higher survival rates, 16 months, compared to 8.3 months in the standard group.
Watch or read the Local 12 story.
Featured photo at top of an IV. Photo/Amornrat Phuchom/iStock Photo.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.